These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 8669389)

  • 21. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
    Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Isolation and analysis of the drug resistance of the flavobacterium and its production of beta-lactamases].
    Luo Y; Xia PY; Wang XY; Yin CH
    Zhonghua Shao Shang Za Zhi; 2004 Feb; 20(1):14-6. PubMed ID: 15059441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H; Azap OK; Ergönül O; Timurkaynak F;
    J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Addressing the challenge of extended-spectrum beta-lactamases.
    Zahar JR; Lortholary O; Martin C; Potel G; Plesiat P; Nordmann P
    Curr Opin Investig Drugs; 2009 Feb; 10(2):172-80. PubMed ID: 19197795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain.
    Gobernado M; Valdés L; Alós JI; García-Rey C; Dal-Ré R; García-de-Lomas J;
    Rev Esp Quimioter; 2007 Mar; 20(1):68-76. PubMed ID: 17530038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibiotic resistance in community-acquired respiratory tract infections: current issues.
    Spach DH; Black D
    Ann Allergy Asthma Immunol; 1998 Oct; 81(4):293-302; quiz 302-3. PubMed ID: 9809491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Extended spectrum beta lactamase forming pathogens (ESBL)].
    Gastmeier P
    Med Klin Intensivmed Notfmed; 2012 Nov; 107(8):592-3. PubMed ID: 23138656
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro evaluation of a new cefixime-clavulanic acid combination for gram-negative bacteria.
    Rawat D; Hasan AS; Capoor MR; Sarma S; Nair D; Deb M; Pillai P; Aggarwal P
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):131-9. PubMed ID: 19323045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
    Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J
    J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [beta-lactam-antibiotics in the treatment of community-acquired respiratory tract infections with penicillin-resistant pneumococci].
    Brauers J; Ewig S; Kresken M
    Pneumologie; 2002 Oct; 56(10):605-9. PubMed ID: 12375222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and molecular analysis of extended-spectrum {beta}-lactamase-producing enterobacteria in the community setting.
    Arpin C; Dubois V; Maugein J; Jullin J; Dutilh B; Brochet JP; Larribet G; Fischer I; Quentin C
    J Clin Microbiol; 2005 Oct; 43(10):5048-54. PubMed ID: 16207960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacteriologic features and antimicrobial susceptibility in isolates from orofacial odontogenic infections.
    Kuriyama T; Karasawa T; Nakagawa K; Saiki Y; Yamamoto E; Nakamura S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Nov; 90(5):600-8. PubMed ID: 11077383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antibiotherapy for acute CAP in adults].
    Denes E
    Med Mal Infect; 2006; 36(11-12):718-33. PubMed ID: 17092678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Study on antimicrobial susceptibility of bacteria causing neonatal infections: a 12 year study (1987-1998).
    Yu JL; Wu SX; Jia HQ
    Singapore Med J; 2001 Mar; 42(3):107-10. PubMed ID: 11405560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Patterns of susceptibility to antibiotics of Enterobacteriaceae causing intra-abdominal infection in Spain: SMART 2003 study outcomes].
    Baquero F; Cercenado E; Cisterna R; de la Rosa M; García-Rodríguez JA; Gobernado M; Pérez JL; Manchado P; Martín R; Pascual A; Picazo J; Prats G; Rubio C; Snyder TA; Sanz-Rodríguez C
    Rev Esp Quimioter; 2006 Mar; 19(1):51-9. PubMed ID: 16688292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rational approach to limiting emergence of antimicrobial drug resistance.
    Mbori-Ngacha DA
    East Afr Med J; 1997 Mar; 74(3):187-9. PubMed ID: 9185420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    Rodríguez-Baño J; Alcalá JC; Cisneros JM; Grill F; Oliver A; Horcajada JP; Tórtola T; Mirelis B; Navarro G; Cuenca M; Esteve M; Peña C; Llanos AC; Cantón R; Pascual A
    Arch Intern Med; 2008 Sep; 168(17):1897-902. PubMed ID: 18809817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reducing antimicrobial resistance in the community by restricting prescribing: can it be done?
    Enne VI
    J Antimicrob Chemother; 2010 Feb; 65(2):179-82. PubMed ID: 20008449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibiotic adjuvants: multicomponent anti-infective strategies.
    Kalan L; Wright GD
    Expert Rev Mol Med; 2011 Feb; 13():e5. PubMed ID: 21342612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of new beta-lactam antibiotics in urinary tract infections.
    Kosmidis J
    Scand J Infect Dis Suppl; 1984; 42():151-4. PubMed ID: 6396836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.